InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Khattar Jack A., Chief Executive Officer. Officer active across 3 companies, notably Supernus Pharmaceuticals, INC.. Cumulatively, 58 reports have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €17k. History available since 30 July 2021. The latest transaction was filed on 12 August 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Khattar Jack A.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations58 total
29,849 shares0Common StockSEC:0001539937-26-000012:0
12,642 shares@ US$46.57Common StockSEC:0001539937-26-000012:1
25,000 sharesCommon StockSEC:0001104659-26-076477:0
12,500 sharesCommon StockSEC:0001539937-26-000008:0
38,640 shares0Common StockSEC:0001539937-26-000006:0
81,250 shares@ US$25.300.062% mcap22.8% of flowCommon StockSEC:0001628280-25-044830:0
5,000 sharesCommon StockSEC:0001193125-25-233528:0
20,000 shares0Common StockSEC:0001539937-25-000030:0
2,267 shares@ US$25.300.0017% mcap0.6% of flowCommon StockSEC:0001539937-25-000028:0
53,785 shares@ US$25.300.041% mcap14.9% of flowCommon StockSEC:0001539937-25-000026:0
11,510 shares@ US$25.300.0087% mcap3.2% of flowCommon StockSEC:0001539937-25-000024:0
13,688 shares@ US$25.303.0% of flowCommon StockSEC:0001539937-25-000022:0
47,940 shares@ US$12.985.3% of flowCommon StockSEC:0001539937-25-000020:0
27,060 shares@ US$12.983.3% of flowCommon StockSEC:0001539937-25-000018:0
8,074 shares@ US$25.302.0% of flowCommon StockSEC:0001539937-25-000014:0
73,176 shares@ US$25.3018.0% of flowCommon StockSEC:0001539937-25-000012:0
17,195 shares@ US$12.982.7% of flowCommon StockSEC:0001539937-25-000010:0
1,611 shares@ US$12.980.3% of flowCommon StockSEC:0001539937-25-000008:0
2,415 shares@ US$12.980.4% of flowCommon StockSEC:0001539937-25-000006:0
60,000 shares@ US$12.980.023% mcap8.6% of flowCommon StockSEC:0001628280-25-039302:0
34,000 shares0Common StockSEC:0001062993-25-012082:0
16,850 sharesCommon StockSEC:0001628280-25-016516:0
35,000 shares0Common StockSEC:0001628280-25-012005:0
38,640 shares0Common StockSEC:0001628280-25-011338:0
38,640 shares0Common StockSEC:0001628280-24-052573:0
25 of 58 declarations
About Khattar Jack A.
Khattar Jack A. is Directeur Général and has filed 56 disclosures. In the sampled disclosures, all dated between 2021-07-30 and 2026-06-22, purchases total 17308 EUR, sales total 0 EUR, and the most common transaction nature is Levée d'options. The main disclosures concern Supernus Pharmaceuticals, INC., including amounts of 1777231.704868656 EUR on 2025-10-10, 1588201.507313002 EUR on 2025-09-08, 1159667.355164488 EUR on 2025-10-02, 1063302.565843188 EUR on 2024-11-08, 1057185.519709414 EUR on 2024-11-12, and 667743.1337232443 EUR on 2025-08-08. He is also linked to Cognition Therapeutics INC and scPharmaceuticals Inc.
